DOI QR코드

DOI QR Code

Stereotactic Body Radiation Therapy for Treatment of Spinal Bone Metastasis

  • Published : 2016.04.11

Abstract

Stereotactic body radiation therapy (SBRT) appears an effective and safe treatment modality for spinal bone metastasis, which can enhance local control and improve quality of life. Life expectation, predicted fracture risk, localization, quality, size and number of metastasis and presence or absence of nerve compression seem to be important factors in decision-making for treatment. Further studies are needed to identify subsets of patient which will most benefit from treatment.

Keywords

References

  1. Chow E, Harris K, Fan G, et al (2007). Palliative radiotherapy trials for bone metastases: A systematic review. J Clin Oncol, 25, 1423-36. https://doi.org/10.1200/JCO.2006.09.5281
  2. De Bari B, Alongi F, Mortellaro G, et al (2015). Spinal metastases: Is stereotactic body radiation therapy supported by evidences? Crit Rev Oncol Hematol. [Epub ahead of print]
  3. Germano IM, Carai A, Pawha P, et al (2015). Clinical outcome of vertebral compression fracture after single fraction spine radiosurgery for spinalmetastases. Clin Exp Metastasis. 2015 Nov 17. [Epub ahead of print]
  4. Gerszten PC, Burton SA, Ozhasoglu C, et al (2007). Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine (Phila Pa 1976), 32, 193-9. https://doi.org/10.1097/01.brs.0000251863.76595.a2
  5. Mantel F, Glatz S, Toussaint A, et al (2014). Long-term safety and efficacy of fractionated stereotactic body radiation therapy for spinal metastases. Strahlenther Onkol, 90, 1141-8.
  6. Moussazadeh N, Lis E, Katsoulakis E, et al (2015). Five-year outcomes of high-dose single-fraction spinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys, 93, 361-7. https://doi.org/10.1016/j.ijrobp.2015.05.035
  7. Murai T, Murata R, Manabe Y, et al (2014). Intensity modulated stereotactic body radiation therapy for single or multiple vertebral metastases with spinal cord compression. Pract Radiat Oncol, 4, 231-7. https://doi.org/10.1016/j.prro.2014.02.005
  8. Park HJ, Kim HJ, Won JH, et al (2015). Stereotactic body radiotherapy (SBRT) for spinal metastases: who will benefit the most from SBRT? Technol Cancer Res Treat, 14, 159-67. https://doi.org/10.7785/tcrt.2012.500411
  9. Price P, Hoskin PJ, Easton D, et al (1988). Low dose single fraction radiotherapy in the treatment of metastatic bone pain: A pilot study. Radiother Oncol, 12, 297-300. https://doi.org/10.1016/0167-8140(88)90019-9
  10. Thibault I, Campbell M, Tseng CL, et al (2015). Salvage stereotactic body radiotherapy (SBRT) following in-field failure of initial SBRT for spinal metastases. Int J Radiat Oncol Biol Phys, 93, 353-60. https://doi.org/10.1016/j.ijrobp.2015.03.029

Cited by

  1. Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma vol.19, pp.1, 2019, https://doi.org/10.1186/s12885-019-5266-4